South Korea will make sickness and death caused by workplace harassment eligible for compensation under the Accident Compensation Act for Public Servants.
According to the Ministry of Personnel Management, the revision of the Accident Compensation Act for Public Servants has passed the Cabinet meeting to set a legal foundation for compensation for public servants who suffer from illnesses due to workplace harassment.
Based on the ministry's administrative regulation on occupational diseases for public servants, the government has so far paid compensation for illness, disability, and death caused by workplace harassment.
However, the change will pave the way for compensation following the Accident Compensation Act for Public Servants.
The revision, according to the ministry, is intended to enhance national responsibility and ensure greater protection for public employees who suffer from workplace abuse that might result in mental trauma.
Gabjil 119, an advocacy group for workplace bullying victims, analyzed that nine out of 18 workers who died following workplace harassment last year were affiliated with public institutions.


Oil Prices Slide Nearly 3% as U.S.-Iran Talks Ease Geopolitical Tensions
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
China and Uruguay Strengthen Strategic Partnership Amid Shifting Global Order
Brazil Supreme Court Orders Asset Freeze of Nelson Tanure Amid Banco Master Investigation
RBA Raises Interest Rates by 25 Basis Points as Inflation Pressures Persist
Federal Judge Blocks Trump Administration Move to End TPS for Haitian Immigrants
U.S. Stock Futures Slip as Markets Brace for Big Tech Earnings and Key Data
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case
Trump Lawsuit Against JPMorgan Signals Rising Tensions Between Wall Street and the White House
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Gold and Asian Stocks Rebound as Market Volatility Eases and Global Sentiment Improves 



